Literature DB >> 28266206

Characterization of Calcium Phosphate Nanoparticles Based on a PEGylated Chelator for Gene Delivery.

Xiangang Huang1, Diana Andina1, Jingshui Ge1, Anne Labarre2, Jean-Christophe Leroux1, Bastien Castagner2.   

Abstract

Calcium phosphate (CaP) nanoparticles are promising gene delivery carriers due to their bioresorbability, ease of preparation, high gene loading efficacy, and endosomal escape properties. However, the rapid aggregation of the particles needs to be addressed in order to have potential in vivo. In addition, there is a need to better understand the relationship between CaP nanoparticle properties and their interactions with cells. Here, a new synthesis route involving click chemistry was developed to prepare the PEGylated chelator PEG-inositol 1,3,4,5,6-pentakisphosphate (PEG-IP5) that can coat and stabilize CaP nanoparticles. Two methods (1 and 2) differing on the time of addition of the PEGylated chelator were employed to produce stabilized particles. Method 1 yielded amorphous aggregated spheres with a particle size of about 200 nm, whereas method 2 yielded 40 nm amorphous loose aggregates of clusters, which were quickly turned into needle bundle-like crystals of about 80 nm in a few hours. Nanoparticles prepared by method 1 were internalized with significantly higher efficiency in HepG2 cells than those prepared by method 2, and the uptake was dramatically influenced by the reaction time of Ca2+ and PO43- and sedimentation of the particles. Interestingly, morphological transformations were observed for both types of particles after different storage times, but this barely influenced their in vitro cellular uptake. The transfection efficiency of the particles prepared by method 1 was significantly higher, and none of the formulations tested showed signs of cytotoxicity. This study provides a better understanding of the properties (e.g., size, morphology, and crystallinity) of PEGylated CaP nanoparticles and how these influence the particles' in vitro uptake and transfection efficiency.

Entities:  

Keywords:  PEGylated chelator; calcium phosphate nanoparticles; gene delivery; morphological transformations; particle properties

Mesh:

Substances:

Year:  2017        PMID: 28266206     DOI: 10.1021/acsami.6b15925

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  10 in total

1.  DNA-Templated Strontium-Doped Calcium Phosphate Nanoparticles for Gene Delivery in Bone Cells.

Authors:  Razieh Khalifehzadeh; Hamed Arami
Journal:  ACS Biomater Sci Eng       Date:  2019-05-22

2.  Calcium-based nanomaterials and their interrelation with chitosan: optimization for pCRISPR delivery.

Authors:  Navid Rabiee; Mojtaba Bagherzadeh; Amir Mohammad Ghadiri; Mahsa Kiani; Sepideh Ahmadi; Vahid Jajarmi; Yousef Fatahi; Abdullah Aldhaher; Mohammadreza Tahriri; Thomas J Webster; Ebrahim Mostafavi
Journal:  J Nanostructure Chem       Date:  2021-09-22

Review 3.  Biodegradable calcium phosphate nanoparticles for cancer therapy.

Authors:  Razieh Khalifehzadeh; Hamed Arami
Journal:  Adv Colloid Interface Sci       Date:  2020-04-10       Impact factor: 12.984

4.  Biofabrication of streptomycin-conjugated calcium phosphate nanoparticles using red ginseng extract and investigation of their antibacterial potential.

Authors:  Gitishree Das; Kwang-Hyun Baek; Jayanta Kumar Patra
Journal:  PLoS One       Date:  2019-06-10       Impact factor: 3.240

5.  Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies.

Authors:  Anna Kletzmayr; Shrikant R Mulay; Manga Motrapu; Zhi Luo; Hans-Joachim Anders; Mattias E Ivarsson; Jean-Christophe Leroux
Journal:  Adv Sci (Weinh)       Date:  2020-02-27       Impact factor: 16.806

6.  Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers.

Authors:  Antonia E Schantl; Anja Verhulst; Ellen Neven; Geert J Behets; Patrick C D'Haese; Marc Maillard; David Mordasini; Olivier Phan; Michel Burnier; Dany Spaggiari; Laurent A Decosterd; Mark G MacAskill; Carlos J Alcaide-Corral; Adriana A S Tavares; David E Newby; Victoria C Beindl; Roberto Maj; Anne Labarre; Chrismita Hegde; Bastien Castagner; Mattias E Ivarsson; Jean-Christophe Leroux
Journal:  Nat Commun       Date:  2020-02-05       Impact factor: 14.919

7.  Enhance transgene responses through improving cellular uptake and intracellular trafficking by bio-inspired non-viral vectors.

Authors:  Xi-Xi Ma; Jing-Liang Xu; Yi-Yang Jia; Ya-Xuan Zhang; Wei Wang; Chen Li; Wei He; Si-Yuan Zhou; Bang-Le Zhang
Journal:  J Nanobiotechnology       Date:  2020-01-31       Impact factor: 10.435

8.  Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery.

Authors:  Franziska Mitrach; Maximilian Schmid; Magali Toussaint; Sladjana Dukic-Stefanovic; Winnie Deuther-Conrad; Heike Franke; Alexander Ewe; Achim Aigner; Christian Wölk; Peter Brust; Michael C Hacker; Michaela Schulz-Siegmund
Journal:  Pharmaceutics       Date:  2022-01-29       Impact factor: 6.321

Review 9.  Carbon quantum dots and their biomedical and therapeutic applications: a review.

Authors:  Mohammad Jafar Molaei
Journal:  RSC Adv       Date:  2019-02-25       Impact factor: 4.036

10.  A Ternary Synergistic eNOS Gene Delivery System Based on Calcium Ion and L-Arginine for Accelerating Angiogenesis by Maximizing NO Production.

Authors:  Guiming Zhang; Shangcong Han; Lisheng Wang; Yu Yao; Kai Chen; Si Chen
Journal:  Int J Nanomedicine       Date:  2022-05-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.